Nanjing Hicin Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002F44
CNY
42.40
-0.31 (-0.73%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
160.34
199.52
162.95
165.92
142.65
143.86
123.97
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
160.34
199.52
162.95
165.92
142.65
143.86
123.97
Raw Material Cost
34.56
51.56
47.39
33.68
29.80
34.07
33.39
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.45
1.73
1.40
1.75
1.77
2.16
2.23
Selling and Distribution Expenses
97.68
98.99
89.83
93.81
84.12
86.52
66.38
Other Expenses
0.31
0.70
1.23
1.03
0.21
0.33
1.17
Total Expenditure (Excl Depreciation)
136.75
159.25
150.97
139.59
117.78
126.03
113.74
Operating Profit (PBDIT) excl Other Income
23.599999999999998
40.300000000000004
12
26.299999999999997
24.900000000000002
17.8
10.2
Other Income
-0.06
-2.27
1.84
0.47
0.38
0.88
-0.18
Operating Profit (PBDIT)
17.90
54.88
22.87
32.27
32.44
26.36
18.48
Interest
1.45
1.73
1.40
1.75
1.77
2.16
2.23
Exceptional Items
0.00
-22.69
0.00
0.00
0.00
-0.00
0.00
Gross Profit (PBDT)
125.78
147.96
115.56
132.24
112.85
109.79
90.57
Depreciation
0.00
18.00
17.95
14.32
14.32
13.43
13.43
Profit Before Tax
16.45
12.45
3.52
16.20
16.35
10.82
2.82
Tax
-1.35
3.91
0.20
1.06
1.39
-1.23
-0.56
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.36
9.38
3.52
14.12
15.04
12.10
3.38
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.36
9.38
3.52
14.12
15.04
12.10
3.38
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.03
-0.84
-0.20
-0.21
-0.07
-0.05
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
16.33
8.54
3.32
13.92
14.96
12.05
3.38
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,070.60
1,053.27
1,043.33
1,039.99
1,037.96
1,022.94
1,010.06
Earnings per share (EPS)
0.14
0.08
0.03
0.12
0.13
0.1
0.03
Diluted Earnings per share
0.14
0.08
0.03
0.12
0.13
0.1
0.03
Operating Profit Margin (Excl OI)
11.2%
19.62%
1.89%
10.54%
12.44%
8.38%
4.22%
Gross Profit Margin
10.26%
15.26%
13.17%
18.4%
21.5%
16.85%
13.11%
PAT Margin
10.83%
4.7%
2.16%
8.51%
10.54%
8.41%
2.73%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -19.65% vs 22.39% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 91.76% vs 157.58% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -68.53% vs 172.38% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -17.65% vs 21.43% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Nanjing Hicin Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
160.34
0
160.34
Other Operating Income
0.00
0.00
0.00
Total Operating income
160.34
0
160.34
Raw Material Cost
34.56
0
34.56
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.45
0
1.45
Selling and Distribution Expenses
97.68
0
97.68
Other Expenses
0.31
0.00
0.31
Total Expenditure (Excl Depreciation)
136.75
0
136.75
Operating Profit (PBDIT) excl Other Income
23.59
0.00
23.59
Other Income
-0.06
0
-0.06
Operating Profit (PBDIT)
17.90
0
17.90
Interest
1.45
0
1.45
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
125.78
0
125.78
Depreciation
0.00
0
0.00
Profit Before Tax
16.45
0
16.45
Tax
-1.35
0
-1.35
Provisions and contingencies
0
0
0.00
Profit After Tax
17.36
0
17.36
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
17.36
0
17.36
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.03
0
-1.03
Other related items
0.00
0.00
0.00
Consolidated Net Profit
16.33
0
16.33
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,070.60
0
1,070.60
Earnings per share (EPS)
0.14
0
0.14
Diluted Earnings per share
0.14
0
0.14
Operating Profit Margin (Excl OI)
11.20%
0%
0.00
11.20%
Gross Profit Margin
10.26%
0%
0.00
10.26%
PAT Margin
10.83%
0%
0.00
10.83%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 16.03 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -19.65% vs 22.39% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 12.41% vs 36.33% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.63 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 91.76% vs 157.58% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 8.67% vs 11.94% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.80 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -68.53% vs 172.38% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -43.93% vs 3.22% in Mar 2025

Quarterly - Interest
Interest 0.14 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -17.65% vs 21.43% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -22.22% vs -14.29% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.20%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025